BR112014011630A2 - composições e métodos para redução de lesões neuronais devido à isquemia - Google Patents
composições e métodos para redução de lesões neuronais devido à isquemiaInfo
- Publication number
- BR112014011630A2 BR112014011630A2 BR112014011630A BR112014011630A BR112014011630A2 BR 112014011630 A2 BR112014011630 A2 BR 112014011630A2 BR 112014011630 A BR112014011630 A BR 112014011630A BR 112014011630 A BR112014011630 A BR 112014011630A BR 112014011630 A2 BR112014011630 A2 BR 112014011630A2
- Authority
- BR
- Brazil
- Prior art keywords
- ischemia
- compositions
- methods
- injury due
- neuronal injury
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1767—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161559816P | 2011-11-15 | 2011-11-15 | |
| PCT/US2012/065291 WO2013074798A1 (en) | 2011-11-15 | 2012-11-15 | Apoaequorin for reducing neuronal injury due to ischemia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112014011630A2 true BR112014011630A2 (pt) | 2017-06-27 |
Family
ID=47295186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112014011630A BR112014011630A2 (pt) | 2011-11-15 | 2012-11-15 | composições e métodos para redução de lesões neuronais devido à isquemia |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20140294874A1 (https=) |
| EP (1) | EP2780027B1 (https=) |
| JP (1) | JP6181061B2 (https=) |
| KR (1) | KR102009932B1 (https=) |
| CN (1) | CN104244966B (https=) |
| AU (1) | AU2012340446B2 (https=) |
| BR (1) | BR112014011630A2 (https=) |
| CA (1) | CA2855719C (https=) |
| CY (1) | CY1119300T1 (https=) |
| DK (1) | DK2780027T3 (https=) |
| ES (1) | ES2643392T3 (https=) |
| HR (1) | HRP20171532T1 (https=) |
| HU (1) | HUE035017T2 (https=) |
| IL (1) | IL232494B (https=) |
| IN (1) | IN2014CN04009A (https=) |
| LT (1) | LT2780027T (https=) |
| MX (1) | MX350259B (https=) |
| PL (1) | PL2780027T3 (https=) |
| PT (1) | PT2780027T (https=) |
| SG (1) | SG11201402364WA (https=) |
| SI (1) | SI2780027T1 (https=) |
| WO (1) | WO2013074798A1 (https=) |
| ZA (1) | ZA201403577B (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA40959A (fr) * | 2014-11-11 | 2017-09-19 | Quincy Bioscience Llc | Compositions contenant de l'apoaéquorine et leurs procédés d'utilisation pour traiter l'inflammation neuronale |
| KR20180001229A (ko) | 2016-06-27 | 2018-01-04 | 삼성에스디아이 주식회사 | 이차 전지의 제조 방법 및 이를 이용한 이차 전지 |
| SI3515212T1 (sl) * | 2016-09-23 | 2024-10-30 | Quincy Bioscience Llc | Sestavki, ki vsebujejo apoaequorin in vitamin d, ter načini njihove uporabe |
| RU2642961C1 (ru) * | 2017-02-21 | 2018-01-29 | Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") | Способ профилактики ишемии головного мозга |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20060229243A1 (en) * | 2004-06-21 | 2006-10-12 | Quincy Resource Group, Inc. | Aequorin-containing compositions and methods of using same |
| GB0602992D0 (en) * | 2006-02-15 | 2006-03-29 | Morvus Technology Ltd | Methods, genes and proteins |
| BRPI0909435A2 (pt) * | 2008-03-11 | 2017-06-13 | Quincy Bioscience Llc | composição e método para tratar de um sintoma ou distúrbio associado com o desequilíbrio do cálcio, uso da apoequorina, e, apoaequorina |
| JP5919604B2 (ja) * | 2008-08-08 | 2016-05-18 | イミューノメディクス、インコーポレイテッドＩｍｍｕｎｏｍｅｄｉｃｓ， Ｉｎｃ． | 抗膵癌抗体 |
| US20110130336A1 (en) * | 2009-10-16 | 2011-06-02 | Quincy Bioscience, Llc | Method of treating ischemic injury using apoaequorin |
-
2012
- 2012-11-15 KR KR1020147016261A patent/KR102009932B1/ko active Active
- 2012-11-15 LT LTEP12795955.9T patent/LT2780027T/lt unknown
- 2012-11-15 SI SI201231064T patent/SI2780027T1/sl unknown
- 2012-11-15 BR BR112014011630A patent/BR112014011630A2/pt not_active Application Discontinuation
- 2012-11-15 DK DK12795955.9T patent/DK2780027T3/en active
- 2012-11-15 AU AU2012340446A patent/AU2012340446B2/en active Active
- 2012-11-15 IN IN4009CHN2014 patent/IN2014CN04009A/en unknown
- 2012-11-15 WO PCT/US2012/065291 patent/WO2013074798A1/en not_active Ceased
- 2012-11-15 MX MX2014005798A patent/MX350259B/es active IP Right Grant
- 2012-11-15 PL PL12795955T patent/PL2780027T3/pl unknown
- 2012-11-15 US US14/358,274 patent/US20140294874A1/en not_active Abandoned
- 2012-11-15 SG SG11201402364WA patent/SG11201402364WA/en unknown
- 2012-11-15 CA CA2855719A patent/CA2855719C/en active Active
- 2012-11-15 JP JP2014542463A patent/JP6181061B2/ja active Active
- 2012-11-15 HU HUE12795955A patent/HUE035017T2/en unknown
- 2012-11-15 HR HRP20171532TT patent/HRP20171532T1/hr unknown
- 2012-11-15 ES ES12795955.9T patent/ES2643392T3/es active Active
- 2012-11-15 EP EP12795955.9A patent/EP2780027B1/en active Active
- 2012-11-15 CN CN201280066993.1A patent/CN104244966B/zh active Active
- 2012-11-15 PT PT127959559T patent/PT2780027T/pt unknown
-
2014
- 2014-05-07 IL IL232494A patent/IL232494B/en active IP Right Grant
- 2014-05-16 ZA ZA2014/03577A patent/ZA201403577B/en unknown
-
2017
- 2017-08-08 CY CY20171100851T patent/CY1119300T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK2780027T3 (en) | 2017-09-25 |
| IL232494B (en) | 2019-03-31 |
| LT2780027T (lt) | 2017-10-25 |
| HUE035017T2 (en) | 2018-03-28 |
| HK1202417A1 (en) | 2015-10-02 |
| ZA201403577B (en) | 2015-07-29 |
| NZ624736A (en) | 2016-05-27 |
| SG11201402364WA (en) | 2014-09-26 |
| EP2780027B1 (en) | 2017-07-19 |
| MX350259B (es) | 2017-08-31 |
| AU2012340446B2 (en) | 2017-08-31 |
| IL232494A0 (en) | 2014-06-30 |
| US20140294874A1 (en) | 2014-10-02 |
| HRP20171532T1 (hr) | 2017-11-17 |
| CY1119300T1 (el) | 2018-02-14 |
| CA2855719A1 (en) | 2013-05-23 |
| ES2643392T3 (es) | 2017-11-22 |
| KR102009932B1 (ko) | 2019-08-12 |
| AU2012340446A1 (en) | 2014-05-29 |
| PL2780027T3 (pl) | 2017-11-30 |
| CA2855719C (en) | 2021-10-26 |
| JP6181061B2 (ja) | 2017-08-16 |
| JP2014533692A (ja) | 2014-12-15 |
| EP2780027A1 (en) | 2014-09-24 |
| PT2780027T (pt) | 2017-10-04 |
| KR20140097369A (ko) | 2014-08-06 |
| CN104244966A (zh) | 2014-12-24 |
| CN104244966B (zh) | 2019-01-11 |
| SI2780027T1 (sl) | 2017-11-30 |
| MX2014005798A (es) | 2014-05-30 |
| WO2013074798A1 (en) | 2013-05-23 |
| IN2014CN04009A (https=) | 2015-10-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112013019732A2 (pt) | composições e métodos para tratamento de doenças cardiovasculares | |
| BR112014009528A2 (pt) | métodos e composições para tratar eritropoiese ineficaz | |
| BR112013031813A2 (pt) | composição para aplicação tópica | |
| PT2890780T (pt) | Métodos e composições para tratamento de uma condição genética | |
| BRDI7106210S (pt) | Configuração aplicada para lâmina para microscópio | |
| BR112013033944A2 (pt) | combinação sinérgica | |
| BR302012006030S1 (pt) | Configuracao aplicada em carenagem lateral para motocicleta | |
| BR302012005911S1 (pt) | Configuração aplicada em carenagem lateral para motocicleta | |
| BR302013001048S1 (pt) | Configuração aplicada em componente para lentes | |
| EP2729131A4 (en) | TOPICAL COMPOSITIONS | |
| EP2787837A4 (en) | COMMONLY DECOMPOSED STABILIZER COMPOSITION | |
| EP2780281A4 (en) | GRAPH COMPOSITIONS | |
| PL2744519T3 (pl) | Kompozycje odmładzające do skóry | |
| EP2718374A4 (en) | CORE CASE MICRO BALLS | |
| BR302013000103S1 (pt) | Configuração aplicada em carenagem lateral para motocicleta | |
| BR112014016389A2 (pt) | composições e métodos para o tratamento de doenças e distúrbios hepáticos | |
| CO6890100A2 (es) | Tratamientos de combinación para hepatitis c | |
| BR112014004414A2 (pt) | composições e métodos para tratar doença neurodegenerativa | |
| PT2718434T (pt) | Composições e métodos para tratar a doença de espru celíaco | |
| BRDI7105327S (pt) | Configuração aplicada em estojo para peças de dominó | |
| BR112014011630A2 (pt) | composições e métodos para redução de lesões neuronais devido à isquemia | |
| EP2881109A4 (en) | TIGECYCLINE COMPOSITION FOR INJECTION | |
| BR112014015532A8 (pt) | embalagem e processo para proporcionar uma embalagem | |
| BR112013031220A2 (pt) | composição tópica | |
| PL2617412T3 (pl) | Kompozycja do leczenia miejscowego |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
| B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
| B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B09B | Patent application refused [chapter 9.2 patent gazette] | ||
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B25G | Requested change of headquarter approved |
Owner name: QUINCY BIOSCIENCE, LLC (US) |
|
| B25A | Requested transfer of rights approved |
Owner name: STILLWATERS BIOSCIENCE GROUP, LLC (US) |